Mon. Nov 28th, 2022
Zydus Cadila files investigational new drug application for COVID-19 treatment “Following up on its initiatives to fight COVID-19 with diagnostics, vaccines and therapeutics, the company is now focussing on cutting edge research to bring targeted therapies… it has filed the IND application of ZYIL1, a novel oral small molecule,” the company said in a regulatory filing.